Subscribe
Canakinumab for Severe COVID-19, Medical Debt in the US, Novel Lipid-Lowering Therapies, and more

JAMA Editor’s Summary

Canakinumab for Severe COVID-19, Medical Debt in the US, Novel Lipid-Lowering Therapies, and more

Editors' Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the issue.
July 20, 2021

Canakinumab for Severe COVID-19, Medical Debt in the US, Novel Lipid-Lowering Therapies, and more

Editors’ Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the July 20, 2021 issue.

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
S1.Ep1: The promise of Personalised Health: Is this the Future of Healthcare? An introduction to the promise and potential of personalised health